Showing 18,261 - 18,280 results of 74,121 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.01s Refine Results
  1. 18261

    Data_Sheet_4_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

    Published 2023
    “…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”
  2. 18262

    Table1_Effectiveness of dapagliflozin as an insulin adjunct in type 1 diabetes: a semi-mechanistic exposure-response model.DOC by Victor Sokolov (14181554)

    Published 2023
    “…Even so, this association remained flat, with a 50% decrease in the basal insulin dose from pretreatment level, resulting in ∼5% increase in glucose exposure. …”
  3. 18263
  4. 18264

    Associations of baseline plasma BK and the sum of all unmodified bradykinin peptides with the ratio (5-year/baseline) of Sv(PGBM/glom) in the 243 RASS participants. by Kevin M. Wheelock (4237609)

    Published 2017
    “…Values above the dashed line reflect an increase in Sv(PGBM/glom) and those below the line a decrease over 5 years.</p>…”
  5. 18265

    Expression of the miR-34 family, Axl and HNF4A in RCC. by Helena K. Fritz (785130)

    Published 2015
    “…<p>The levels of miR-34a, Axl mRNA, and HNF4A mRNA were determined using RT-qPCR in a cohort of RCC patients (cohort N = 198, ccRCC N = 152, normal N = 50). …”
  6. 18266

    Schematic overview of molecular processes altered during disease progression in the SN of PD, identified using transcriptome analysis. by Anke A. Dijkstra (756877)

    Published 2015
    “…In addition, we observed down regulation of mRNA levels of the upstream regulators in mTOR pathway. …”
  7. 18267
  8. 18268

    The procurement of innovation by the U.S. government by Gaétan de Rassenfosse (7207697)

    Published 2019
    “…<div><p>The U.S. government invests more than $50 billion per year in R&D procurement but we know little about the outcomes of these investments. …”
  9. 18269
  10. 18270
  11. 18271
  12. 18272
  13. 18273
  14. 18274
  15. 18275
  16. 18276
  17. 18277

    Identification of novel pathogenic mutations in <i>ATP6V0A4</i> associated with distal renal tubular acidosis and analysis of wild-type expression in glomerular disease by Yaru Jiang (17458815)

    Published 2025
    “…Notably, patients with <i>ATP6V0A4</i> mutations were diagnosed at a younger age (mean 0.5 years) and exhibited more severe renal impairment, including reduced estimated glomerular filtration rate (eGFR), indicating heightened susceptibility to kidney damage. …”
  18. 18278
  19. 18279
  20. 18280

    The <i>sf3b1-698</i> mutants are defective in fecundity and lifespan. by Bei Zhang (428038)

    Published 2021
    “…Females of the two sf3b1 mutants laid no significantly changed eggs during the late half of test time. Means: WT = 175, H698D = 195.5, p = 0.5296, H698R = 173.4, p = 0.9437. …”